In a new study, researchers found that there is convincing evidence that type 2 diabetes is associated with an increased risk of Parkinson’s disease.
They found that type 2 diabetes may contribute to faster disease progression in patients who already have Parkinson’s.
The research was conducted by a team from the Queen Mary University of London.
Previous reviews have produced conflicting results around the link between diabetes and the risk of Parkinson’s disease.
In the study, the team used a meta-analysis of observational genetic data to evaluate the effect of type 2 diabetes on the risk and progression of Parkinson’s disease.
This research brings together the results from many other studies to provide convincing evidence that type 2 diabetes likely affects not only Parkinson’s risk but also Parkinson’s progression.
The researchers say that treating people with drugs already available for type 2 diabetes may reduce the risk and slow the progression of Parkinson’s.
Screening for and early treatment of type 2 diabetes in patients with Parkinson’s may be advisable.
There are many treatment strategies for type 2 diabetes, including prevention strategies, which may be re-purposed for the treatment of Parkinson’s.
One author of the study is Dr. Alastair Noyce.
The study is published in the Movement Disorders Journal.
Copyright © 2021 Knowridge Science Report. All rights reserved.